Reference
Orchard Therapeutics. Orchard Statement on Strimvelis, a Gammaretroviral Vector-Based Gene Therapy for ADA-SCID. Internet Document : 30 Oct 2020. Available from: URL: https://ir.orchard-tx.com/news-releases/news-release-details/orchard-statement-strimvelisr-gammaretroviral-vector-based-gene
Rights and permissions
About this article
Cite this article
Strimvelis: risk of lymphoid T-cell leukaemia?. Reactions Weekly 1830, 6 (2020). https://doi.org/10.1007/s40278-020-85956-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-85956-9